Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (3): 297-304.doi: 10.19982/j.issn.1000-6621.20220370
• Original Articles • Previous Articles Next Articles
Cai Yuguo, Zheng Yongli, He Min, Pu Yu()
Received:
2022-09-28
Online:
2023-03-10
Published:
2023-03-07
Contact:
Pu Yu
E-mail:599080188@qq.com
Supported by:
CLC Number:
Cai Yuguo, Zheng Yongli, He Min, Pu Yu. Construction and validation of early diagnosis model of knee joint tuberculosis based on LASSO regression[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 297-304. doi: 10.19982/j.issn.1000-6621.20220370
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220370
因素 | 病例组(136例) | 对照组(136例) | 统计检验值 | P值 |
---|---|---|---|---|
性别 | χ2=5.323 | 0.021 | ||
男性 | 81(59.56) | 62(45.59) | ||
女性 | 55(40.44) | 74(54.41) | ||
年龄(岁, | 45.42±17.86 | 50.74±18.50 | t=2.415 | 0.016 |
BMI指数( | 22.19±2.65 | 22.39±2.72 | t=-0.595 | 0.553 |
IFN-γ释放水平(pg/ml, | 236.67±90.73 | 137.25±32.04 | t=12.050 | <0.001 |
LAM抗体 | χ2=82.693 | <0.001 | ||
阴性 | 42(30.88) | 116(85.29) | ||
阳性 | 94(69.12) | 20(14.71) | ||
GeneXpert MTB/RIF | χ2=74.395 | <0.001 | ||
阴性 | 50(36.76) | 119(87.50) | ||
阳性 | 86(63.24) | 17(12.50) | ||
骨髓水肿 | χ2=19.009 | <0.001 | ||
无 | 83(61.03) | 115(84.56) | ||
有 | 53(38.97) | 21(15.44) | ||
半月板损伤 | χ2=6.380 | 0.012 | ||
无 | 77(56.62) | 97(71.32) | ||
有 | 59(43.38) | 39(28.68) | ||
软骨损伤 | χ2=24.817 | <0.001 | ||
无 | 75(55.15) | 113(83.09) | ||
有 | 61(44.85) | 23(16.91) | ||
周围组织肿胀 | χ2=3.958 | 0.047 | ||
无 | 126(92.65) | 133(97.79) | ||
有 | 10(7.35) | 3(2.21) | ||
骨质破坏 | χ2=6.942 | 0.008 | ||
无 | 127(93.38) | 113(83.09) | ||
有 | 9(6.62) | 23(16.91) | ||
关节间隙狭窄 | χ2=8.957 | 0.003 | ||
无 | 117(86.03) | 131(96.32) | ||
有 | 19(13.97) | 5(3.68) | ||
关节周围脓肿形成 | χ2=9.967 | 0.002 | ||
无 | 111(81.62) | 128(94.12) | ||
有 | 25(18.38) | 8(5.88) | ||
膝关节肿胀 | χ2=0.530 | 0.467 | ||
无 | 64(47.06) | 70(51.47) | ||
有 | 72(52.94) | 66(48.53) | ||
疼痛 | χ2=0.565 | 0.452 | ||
无 | 48(35.29) | 54(39.71) | ||
有 | 88(64.71) | 82(60.29) | ||
局部肌肉萎缩 | χ2=5.723 | 0.017 | ||
无 | 94(69.12) | 111(81.62) | ||
有 | 42(30.88) | 25(18.38) |
因素 | β值 | s | Wald χ2值 | P值 | OR值 | 95%置信区间 | |
---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||
性别 | -0.383 | 0.406 | 0.889 | 0.346 | 0.682 | 0.308 | 1.511 |
年龄 | -0.023 | 0.011 | 4.350 | 0.037 | 0.977 | 0.955 | 0.999 |
IFN-γ释放水平 | 0.005 | 0.002 | 6.250 | 0.012 | 1.005 | 1.001 | 1.009 |
LAM抗体 | 2.731 | 0.451 | 36.706 | <0.001 | 15.348 | 6.344 | 37.130 |
GeneXpert MTB/RIF | 3.048 | 0.477 | 40.905 | <0.001 | 21.073 | 8.281 | 53.628 |
骨髓水肿 | 1.097 | 0.482 | 5.186 | 0.023 | 2.996 | 1.165 | 7.702 |
半月板损伤 | 1.611 | 0.503 | 10.249 | 0.001 | 5.007 | 1.868 | 13.425 |
软骨损伤 | 1.415 | 0.467 | 9.195 | 0.002 | 4.117 | 1.649 | 10.274 |
周围组织肿胀 | 1.684 | 0.491 | 11.775 | 0.001 | 5.389 | 2.059 | 14.102 |
骨质破坏 | 1.090 | 0.698 | 2.436 | 0.119 | 2.973 | 0.757 | 11.682 |
关节周围脓肿形成 | 2.024 | 0.712 | 8.089 | 0.004 | 7.570 | 1.876 | 30.546 |
常量 | -3.486 | 0.927 | 14.156 | <0.001 | 0.031 |
因素 | 例数 | 构成比(%) |
---|---|---|
性别 | ||
男性 | 41 | 56.94 |
女性 | 31 | 43.06 |
LAM抗体 | ||
阴性 | 48 | 66.67 |
阳性 | 24 | 33.33 |
GeneXpert MTB/RIF | ||
阴性 | 45 | 62.50 |
阳性 | 27 | 37.50 |
骨髓水肿 | ||
无 | 43 | 59.72 |
有 | 29 | 40.28 |
半月板损伤 | ||
无 | 37 | 51.39 |
有 | 35 | 48.61 |
软骨损伤 | ||
无 | 39 | 54.17 |
有 | 33 | 45.83 |
周围组织肿胀 | ||
无 | 56 | 77.78 |
有 | 16 | 22.22 |
骨质破坏 | ||
无 | 59 | 81.94 |
有 | 13 | 18.06 |
关节间隙狭窄 | ||
无 | 48 | 66.67 |
有 | 24 | 33.33 |
关节周围脓肿形成 | ||
无 | 46 | 63.89 |
有 | 26 | 36.11 |
膝关节肿胀 | ||
无 | 37 | 51.39 |
有 | 35 | 48.61 |
疼痛 | ||
无 | 32 | 44.44 |
有 | 40 | 55.56 |
局部肌肉萎缩 | ||
无 | 36 | 50.00 |
有 | 36 | 50.00 |
[1] |
杨松, 韩梅, 王乐乐, 等. “2020世界卫生组织结核病整合指南之预防性治疗”解读. 国际呼吸杂志, 2021, 41(3): 161-166. doi:10.3760/cma.j.cn131368-20200914-00824.
doi: 10.3760/cma.j.cn131368-20200914-00824 |
[2] |
Noguera-Julian A, Calzada-Hernández J, Brinkmann F, et al. Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study. Clin Infect Dis, 2020, 71(10): 2561-2569. doi:10.1093/cid/ciz1138.
doi: 10.1093/cid/ciz1138 pmid: 31796965 |
[3] |
Guillouzouic A, Andrejak C, Peuchant O, et al. Treatment of Bone and Joint Tuberculosis in France: A Multicentre Retrospective Study. J Clin Med, 2020, 9(8): 2529. doi:10.3390/jcm9082529.
doi: 10.3390/jcm9082529 URL |
[4] |
Drobish I, Ramchandar N, Raabe V, et al. Pediatric Osteoarticular Infections Caused by Mycobacteria Tuberculosis Complex: A 26-Year Review of Cases in San Diego, CA. Pediatr Infect Dis J, 2022, 41(5): 361-367. doi:10.1097/INF.0000000000003447.
doi: 10.1097/INF.0000000000003447 URL |
[5] |
张贺龙, 王慧燕, 刘威, 等. IGRA、LAM抗体联合Xpert技术检测对膝关节结核的诊断价值及与结核活动性的关系. 临床误诊误治, 2021, 34(10): 84-87, 93. doi:10.3969/j.issn.1002-3429.2021.10.019.
doi: 10.3969/j.issn.1002-3429.2021.10.019 |
[6] | 闫继栋, 桑继涛. 膝关节滑膜病变的MR诊断及鉴别诊断效果观察. 影像研究与医学应用, 2020, 4(11): 8-9. |
[7] |
黄迅悟, 李超. 关节结核与耐药诊断专家共识. 中国矫形外科杂志, 2020, 28(12): 1057-1062. doi:10.3977/j.issn.1005-8478.2020.12.01.
doi: 10.3977/j.issn.1005-8478.2020.12.01 |
[8] |
王连波, 章志华, 刘丰胜, 等. GeneXpert MTB/RIF在膝关节结核诊断及利福平耐药检测中的应用价值. 结核与肺部疾病杂志, 2021, 2(1): 23-25. doi:10.3969/j.issn.2096-8493.2021.01.006.
doi: 10.3969/j.issn.2096-8493.2021.01.006 |
[9] | 李偲. 滑膜型膝关节结核MR伴随征象特征及相关性分析. 沈阳: 中国医科大学, 2020. |
[10] |
Vanino E, Tadolini M, Evangelisti G, et al. Spinal tuberculosis: proposed spinal infection multidisciplinary management project (SIMP) flow chart revision. Eur Rev Med Pharmacol Sci, 2020, 24(3): 1428-1434. doi:10.26355/eurrev_202002_20201.
doi: 10.26355/eurrev_202002_20201 |
[11] |
Jung Y, Choi BY. Differential Diagnosis of Inflammatory Arthropathy Accompanying Active Tuberculosis Infection. J Rheum Dis, 2022, 29(2): 108-115. doi:https://doi.org/10.4078/jrd.2022.29.2.108.
doi: https://doi.org/10.4078/jrd.2022.29.2.108 URL |
[12] |
Lim SL, Ong PS, Khor CG. Multifocal osteoarticular tuberculosis in a systemic lupus erythematosus (SLE) patient: a rarity or an underdiagnosed condition? Mod Rheumatol Case Rep, 2020, 4(2): 237-242. doi:10.1080/24725625.2020.1754567.
doi: 10.1080/24725625.2020.1754567 |
[13] |
Salinas-Álvarez V, Gómez-Torres C, Garzón-Cubides J, et al. Extrapulmonary tuberculosis: mimicking metastases in a patient with melanoma in a high TB-burden country; case report. Radiol Case Rep, 2020, 15(11): 2471-2476. doi:10.1016/j.radcr.2020.08.059.
doi: 10.1016/j.radcr.2020.08.059 URL |
[14] | Barss L, Connors WJA, Fisher D. Chapter 7: Extra-pulmonary tuberculosis. Can J Resp Crit, 2022, 6(sup1): 87-108. |
[15] |
Bhosale PB, Jaiswal R, Purohit S, et al. Total Hip Arthroplasty in 52 Active Advanced Tubercular Arthritic Hips. J Arthroplasty, 2021, 36(3): 1035-1042. doi:10.1016/j.arth.2020.09.016.
doi: 10.1016/j.arth.2020.09.016 URL |
[16] |
Allia N, Rahmawati LD. Management of A Patient with Ankylosing Spondylitis Type Spondyloarthritis and Latent Tuberculosis Infection. Curr Int Med Res Pract Surabaya J, 2021, 2(1): 19-24. doi:10.20473/cimrj.v2i1.23887.
doi: 10.20473/cimrj.v2i1.23887 |
[17] |
Azad KAK, Chowdhury T. Extrapulmonary Tuberculosis (Eptb): An Overview. Bangladesh J Med, 2022, 33(2): 130-137. doi:10.3329/bjm.v33i2.59285.
doi: 10.3329/bjm.v33i2.59285 URL |
[18] |
Biglia A, Morandi V, Monti S, et al. Cobalt hip prosthesis intoxication mimicking an autoimmune disease. Joint Bone Spine, 2020, 87(6): 652-654. doi:10.1016/j.jbspin.2020.05.014.
doi: 10.1016/j.jbspin.2020.05.014 pmid: 32534197 |
[19] |
Lawrensia S. Diagnosis dan Tatalaksana Artritis Tuberkulosis. Cermin Dunia Kedokteran, 2020, 47(8): 417-419.
doi: 10.55175/cdk.v47i8.773 URL |
[20] |
Venetsanopoulou AI, Markatseli TE, Iliou C, et al. Pleural effusion in psoriatic arthritis patients: a case series and review of the literature. Clin Rheumatol, 2021, 40(11): 4741-4748. doi:10.1007/s10067-021-05712-9.
doi: 10.1007/s10067-021-05712-9 pmid: 33782750 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||